Ken Kelley CEO, Founder, IntraBiotics	"Drew and Mark have helped me to become a better leader, and helped evolve the officer group to become a better peak performing team. They have become trusted coaches and a consistent positive force throughout the significant changes in our company since the fall of 1998. The payback on our investment in DNA has been more than ten fold." [Click on photo to hear the client's experience]
Hank Fuchs, M.D. Vice President Clinical Affairs, IntraBiotics	Marti Haskins Senior Director Clinical Affairs, IntraBiotics

The company:
IntraBiotics develops novel antibiotics for the treatment and prevention of serious infectious diseases. Two Phase III clinical trials are underway for FDA approval. The company has more than tripled in size since first retaining DNA, and went public with an IPO in March, 2000 (NASDAQ: IBPI).

The need for DNA:
"As we faced massive growth and change - from a pre-public company with one Phase I clinical trial to a much larger public company with two Phase III trials in progress - we recognized the need to develop leaders throughout the organization. Leaders who would live IntraBiotics' mission and values day to day, thereby continuing the passion and practices that have driven excellent performance to date and created a great, attractive place to work. I recognized the opportunity to start at the top, with a vision for myself and my fellow officers to become a peak performance executive team."
                     -Ken Kelley, CEO

DNA services provided:

• Customized, confidential 360 degree feedback survey for all employees, with action planning and follow up process for encouraging feedback conversations and achieving change in targeted behaviors
• Top Team development offsites, focused both on achieving substantive work product and on process how best to work together
• Departmental team development
• Executive coaching
• Shadow coaching
• Training on giving and receiving feedback
• Organizational development consulting